|
1.
|
Roder DM: The epidemiology of gastric
cancer. Gastric Cancer. 5(Suppl 1): 5–11. 2002. View Article : Google Scholar
|
|
2.
|
Yokota J: Tumor progression and
metastasis. Carcinogenesis. 21:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Greider CW and Blackburn EH: A telomeric
sequence in the RNA of Tetrahymena telomerase required for telomere
repeat synthesis. Nature. 337:331–337. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Sealey DC, Zheng L, Taboski MA,
Cruickshank J, Ikura M and Harrington LA: The N-terminus of hTERT
contains a DNA-binding domain and is required for telomerase
activity and cellular immortalization. Nucleic Acids Res.
38:2019–2035. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Catarino R, Araujo A, Coelho A, Gomes M,
Nogueira A, Lopes C and Medeiros RM: Prognostic significance of
telomerase polymorphism in non-small cell lung cancer. Clin Cancer
Res. 16:3706–3712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Poremba C, Heine B, Diallo R, Heinecke A,
Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bankfalvi A, et
al: Telomerase as a prognostic marker in breast cancer:
high-throughput tissue microarray analysis of hTERT and hTR. J
Pathol. 198:181–189. 2002. View Article : Google Scholar
|
|
7.
|
Horvai AE, Kramer MJ, Garcia JJ and
O'Donnell RJ: Distribution and prognostic significance of human
telomerase reverse transcriptase (hTERT) expression in giant-cell
tumor of bone. Mod Pathol. 21:423–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: a
proposal for reporting. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar
|
|
9.
|
Little J, Bradley L, Bray MS, Clyne M,
Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, et
al: Reporting, appraising, and integrating data on genotype
prevalence and gene-disease associations. Am J Epidemiol.
156:300–310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Whiting PF, Weswood ME, Rutjes AW, Reitsma
JB, Bossuyt PN and Kleijnen J: Evaluation of QUADAS, a tool for the
quality assessment of diagnostic accuracy studies. BMC Med Res
Methodol. 6:92006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Cohen J: A coefficient of agreement for
nominal scales. Educ Psychol Meas. 20:37–46. 1960. View Article : Google Scholar
|
|
13.
|
Greenland S and Robins J: Estimation of a
common effect parameter from sparse follow-up data. Biometrics.
41:55–68. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yang SM, Fang DC, Luo YH, Lu R, Battle PD
and Liu WW: Alterations of telomerase activity and terminal
restriction fragment in gastric cancer and its premalignant
lesions. J Gastroenterol Hepatol. 16:876–882. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hu X, Wu H, Zhang S, Yuan H and Cao L:
Clinical significance of telomerase activity in gastric carcinoma
and peritoneal dissemination. J Int Med Res. 37:1127–1138. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wu CH, Lin SR, Yu FJ, Wu DC, Pan YS, Hsieh
JS, Huang SY and Wang JY: Development of a high-throughput
membrane-array method for molecular diagnosis of circulating tumor
cells in patients with gastric cancers. Int J Cancer. 119:373–379.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wang W, Luo HS and Yu BP: Expression of
NF-kappaB and human telomerase reverse transcriptase in gastric
cancer and precancerous lesions. World J Gastroenterol. 10:177–181.
2004.PubMed/NCBI
|
|
19.
|
Yoo J, Park SY, Kang SJ, Kim BK, Shim SI
and Kang CS: Expression of telomerase activity, human telomerase
RNA, and telomerase reverse transcriptase in gastric
adenocarcinomas. Mod Pathol. 20:700–707. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Yasui W, Tahara H, Tahara E, Fujimoto J,
Nakayama J, Ishikawa F and Ide T: Expression of telomerase
catalytic component, telomerase reverse transcriptase, in human
gastric carcinomas. Jpn J Cancer Res. 89:1099–1103. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kameshima H, Yagihashi A, Yajima T,
Kobayashi D, Denno R, Hirata K and Watanabe N: Helicobacter
pylori infection: augmentation of telomerase activity in cancer
and noncancerous tissues. World J Surg. 24:1243–1249. 2000.
View Article : Google Scholar
|
|
22.
|
Gigek CO, Leal MF, Silva PN, Lisboa LC,
Lima EM, Calcagno DQ, Assumpcao PP, Burbano RR and Smith Mde A:
hTERT methylation and expression in gastric cancer. Biomarkers.
14:630–636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hu LH, Chen FH, Li YR and Wang L:
Real-time determination of human telomerase reverse transcriptase
mRNA in gastric cancer. World J Gastroenterol. 10:3514–3517.
2004.PubMed/NCBI
|
|
24.
|
Ahn MJ, Noh YH, Lee YS, Lee JH, Chung TJ,
Kim IS, Choi IY, Kim SH, Lee JS and Lee KH: Telomerase activity and
its clinicopathological significance in gastric cancer. Eur J
Cancer. 33:1309–1313. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hiyama E, Yokoyama T, Tatsumoto N, Hiyama
K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and
Matsuura Y: Telomerase activity in gastric cancer. Cancer Res.
55:3258–3262. 1995.PubMed/NCBI
|
|
26.
|
Tahara H, Kuniyasu H, Yokozaki H, Yasui W,
Shay JW, Ide T and Tahara E: Telomerase activity in preneoplastic
and neoplastic gastric and colorectal lesions. Clin Cancer Res.
1:1245–1251. 1995.PubMed/NCBI
|
|
27.
|
Liu Xl, Chen P and Wei JM: The
relationship between CK20 mRNA and hTERT mRNA expression in
peripheral blood of patients with gastric carcinoma and tumor
micrometastasis. Chin J Clin Oncol. 35:1286–1289. 2008.
|
|
28.
|
Okusa Y, Shinomiyo N, Ichikura T and
Mochizuki H: Correlation between telomerase activity and DNA ploidy
in gastric cancer. Oncology. 55:258–264. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Shin JH, Chung J, Kim HO, Kim YH, Hur YM,
Rhim JH, Chung HK, Park SC, Park JG and Yang HK: Detection of
cancer cells in peripheral blood of stomach cancer patients using
RT-PCR amplification of tumour-specific mRNAs. Aliment Pharmacol
Ther. 16(Suppl 2): 137–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mori N, Oka M, Hazama S, Iizuka N,
Yamamoto K, Yoshino S, Tangoku A, Noma T and Hirose K: Detection of
telomerase activity in peritoneal lavage fluid from patients with
gastric cancer using immunomagnetic beads. Br J Cancer.
83:1026–1032. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Zhan WH, Ma JP, Peng JS, Gao JS, Cai SR,
Wang JP, Zheng ZQ and Wang L: Telomerase activity in gastric cancer
and its clinical implications. World J Gastroenterol. 5:316–319.
1999.PubMed/NCBI
|
|
32.
|
Gümüx-Akay G, Ünal AE, Bayar S, Karadayi
K, Elhan AH, Sunguroqlu A and Tükün A: Telomerase activity could be
used as a marker for neoplastic transformation in gastric
adenocarcinoma: but it does not have a prognostic significance.
Genet Mol Res. 6:41–49. 2007.(In Bulgarian).
|
|
33.
|
Bulanov D: Gastric Cancer – Current state
of the problem. Part I. Epidemiology. Pathology. Classification.
Staging. Khirurgiia (Sofia). 48–59. 2007.(In Bulgarian).
|
|
34.
|
Beisner J, Dong M, Taetz S, Nafee N,
Griese EU, Schaefer U, Lehr CM, Klotz U and Murdter TE:
Nanoparticle mediated delivery of 2′-O-methyl-RNA leads to
efficient telomerase inhibition and telomere shortening in human
lung cancer cells. Lung Cancer. 68:346–354. 2010.
|
|
35.
|
Lu L, Zhang C, Zhu G, Irwin M, Risch H,
Menato G, Mitidieri M, Katsaros D and Yu H: Telomerase expression
and telomere length in breast cancer and their associations with
adjuvant treatment and disease outcome. Breast Cancer Res.
13:R562011. View
Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Nakamura M, Saito H, Ebinuma H,
Wakabayashi K, Saito Y, Takagi T, Nakamoto N and Ishii H: Reduction
of telomerase activity in human liver cancer cells by a histone
deacetylase inhibitor. J Cell Physiol. 187:392–401. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Capezzone M, Cantara S, Marchisotta S,
Filetti S, De Santi MM, Rossi B, Ronga G, Durante C and Pacini F:
Short telomeres, telomerase reverse transcriptase gene
amplification, and increased telomerase activity in the blood of
familial papillary thyroid cancer patients. J Clin Endocrinol
Metab. 93:3950–3957. 2008. View Article : Google Scholar
|
|
38.
|
Miyachi K, Fujita M, Tanaka N, Sasaki K
and Sunagawa M: Correlation between telomerase activity and
telomeric-repeat binding factors in gastric cancer. J Exp Clin
Cancer Res. 21:269–275. 2002.PubMed/NCBI
|
|
39.
|
Gumus-Akay G, Elhan AH, Unal AE,
Demirkazik A, Sunguroglu A and Tukun A: Effects of genomic
imbalances on telomerase activity in gastric cancer: clues to
telomerase regulation. Oncol Res. 17:455–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Usselmann B, Newbold M, Morris AG and
Nwokolo CU: Telomerase activity and patient survival after surgery
for gastric and oesophageal cancer. Eur J Gastroenterol Hepatol.
13:903–908. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Poole JC, Andrews LG and Tollefsbol TO:
Activity, function, and gene regulation of the catalytic subunit of
telomerase (hTERT). Gene. 269:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Jin X, Beck S, Sohn YW, Kim JK, Kim SH,
Yin J, Pian X, Kim SC, Choi YJ and Kim H: Human telomerase
catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic
response via induction of basic fibroblast growth factor. Exp Mol
Med. 42:574–582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Bagheri S, Nosrati M, Li S, Fong S,
Torabian S, Rangel J, Moore DH, Federman S, Laposa RR, Baehner FL,
et al: Genes and pathways downstream of telomerase in melanoma
metastasis. Proc Natl Acad Sci USA. 103:11306–11311. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Hochreiter AE, Xiao H, Goldblatt EM,
Gryaznov SM, Miller KD, Badve S, Sledge GW and Herbert BS:
Telomerase template antagonist GRN163L disrupts telomere
maintenance, tumor growth, and metastasis of breast cancer. Clin
Cancer Res. 12:3184–3192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim
KS, Lee JJ and Park C: High telomerase activity and long telomeres
in advanced hepatocellular carcinomas with poor prognosis. Lab
Invest. 88:144–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Yu ST, Chen L, Wang HJ, Tang XD, Fang DC
and Yang SM: hTERT promotes the invasion of telomerase-negative
tumor cells in vitro. Int J Oncol. 35:329–336.
2009.PubMed/NCBI
|
|
47.
|
Palli D: Epidemiology of gastric cancer.
Ann Ist Super Sanita. 32:85–99. 1996.
|
|
48.
|
Soler RE, Leeks KD, Razi S, Hopkins DP,
Griffith M, Aten A, Chattopadhyay SK, Smith SC, Habarta N, Goetzel
RZ, et al: A systematic review of selected interventions for
worksite health promotion. The assessment of health risks with
feedback. Am J Prev Med. 38:S237–S262. 2010. View Article : Google Scholar : PubMed/NCBI
|
